Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and ...
Aug 22, 2022
0
177
A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth ...
Aug 17, 2022
0
44
MRSA is an antibiotic-resistant staph infection that can be deadly for those in hospital care or with weakened immune systems. Staphylococcus aureus bacteria live in the nose without necessarily producing any symptoms but ...
Aug 17, 2022
0
21
An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy ...
Aug 9, 2022
0
945
A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the broader population, in ...
Aug 5, 2022
0
20
Alzheimer's disease is the most prevalent form of dementia and, with a rapidly aging global population, it is fueling unprecedented demand for costly patient care. There have been an estimated 400 clinical studies since the ...
Aug 2, 2022
0
45
Research into the "green whistle" pain relief inhaler has found no obvious harm for pregnant women or their newborn babies in a study looking at ambulance cases over 17 years.
Jul 29, 2022
0
0
Research published in the Journal of Thoracic Oncology shows cytisine may be a safe and effective smoking cessation therapy in lung cancer screening volunteers.
Jul 28, 2022
0
1
Researchers at the University of Maryland School of Medicine have begun collecting broad health information from 250,000 volunteers around the state in an effort to uncover better ways of treating and preventing all kinds ...
Jul 28, 2022
0
3
Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...
Jul 25, 2022
0
28
